Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03).

---

Autoria(s): Pesce G.A.; Klingbiel D.; Ribi K.; Zouhair A.; von Moos R.; Schlaeppi M.; Caspar C.B.; Fischer N.; Anchisi S.; Peters S.; Cathomas R.; Bernhard J.; Kotrubczik N.M.; D'Addario G.; Pilop C.; Weber D.C.; Bodis S.; Pless M.; Mayer M.; Stupp R.

Data(s)	2012
Identificador	http://serval.unil.ch/?id=serval:BIB_417EF1578C3A isbn:1879-0852 (Electronic) pmid:22093943 doi:10.1016/j.ejca.2011.10.016 isiid:000300729800012
Idioma(s)	en
Fonte	European Journal of Cancer, vol. 48, no. 3, pp. 377-384
Tipo	info:eu-repo/semantics/article article